News Releases Year None20202019 Mar 30, 2020 Immunovant Announces Positive Clinical Results from Ongoing Phase 2a Proof-of-Concept Study of IMVT-1401, A Novel Investigational Anti-FcRn Antibody Delivered by Subcutaneous Injection, in Thyroid Eye Disease Feb 14, 2020 Immunovant Reports Financial Results for the Quarter and Nine Months Ending December 31, 2019 Feb 10, 2020 Immunovant to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Mar 30, 2020 Immunovant Announces Positive Clinical Results from Ongoing Phase 2a Proof-of-Concept Study of IMVT-1401, A Novel Investigational Anti-FcRn Antibody Delivered by Subcutaneous Injection, in Thyroid Eye Disease
Feb 14, 2020 Immunovant Reports Financial Results for the Quarter and Nine Months Ending December 31, 2019
